Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Change in Cash (2016 - 2025)

Haemonetics (HAE) has 17 years of Change in Cash data on record, last reported at $66.9 million in Q4 2025.

  • For Q4 2025, Change in Cash rose 210.44% year-over-year to $66.9 million; the TTM value through Dec 2025 reached $42.5 million, down 66.48%, while the annual FY2025 figure was $128.0 million, 221.1% up from the prior year.
  • Change in Cash reached $66.9 million in Q4 2025 per HAE's latest filing, up from $3.5 million in the prior quarter.
  • Across five years, Change in Cash topped out at $165.6 million in Q2 2024 and bottomed at -$157.0 million in Q4 2023.
  • Average Change in Cash over 5 years is $8.7 million, with a median of $3.4 million recorded in 2021.
  • Peak YoY movement for Change in Cash: plummeted 813.05% in 2023, then surged 13118.6% in 2024.
  • A 5-year view of Change in Cash shows it stood at $19.0 million in 2021, then crashed by 190.72% to -$17.2 million in 2022, then tumbled by 813.05% to -$157.0 million in 2023, then surged by 113.73% to $21.6 million in 2024, then soared by 210.44% to $66.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were $66.9 million in Q4 2025, $3.5 million in Q3 2025, and -$13.9 million in Q2 2025.